Results 231 to 240 of about 44,539 (322)

Cricopharyngeal myotomy using grasping scissors: Benefits of peroral endoscopic myotomy in symptomatic Zenker’s diverticulum

Endoscopy International Open
Marc Harb, Jean Baptiste Danset, Cynthia Medlij, Olivier Marty, Damien Levoir, Elise Chanteloup, Bernard El Khoury, Christophe Souaid, Yann Le Baleur   +8 more
doaj   +1 more source

Heyde Syndrome: A Literature Review

Health Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background and Aims Heyde syndrome, a triad of anemia from gastrointestinal (GI) bleeding, aortic valve stenosis, and acquired von Willebrand syndrome, primarily affects individuals over 65. Management requires a multidisciplinary approach, including medical therapy, endoscopic intervention, and valve replacement.
Yashika Gupta, Abdul Rehman Shahid Khan, Viraj Shetty, Yeshwini Murali Krishna, Ayisha Maqsood, Muhammad Husnain Ahmad, Masab Ali, Betsy Samuel, Ali Gohar, Abdul Waheed, Muhammad Bilal Afzal, Rehan Naseer Ahmad, Saqib Maqsood   +12 more
wiley   +1 more source

Long-term course of untreated asymptomatic esophageal eosinophilia and minimally symptomatic eosinophilic esophagitis

Endoscopy International Open
Yasuhiko Abe, Ryosuke Kikuchi, Yu Sasaki, Naoko Mizumoto, Makoto Yagi, Yusuke Onozato, Takahiro Watabe, Hiroki Goto, Takahiro Miura, Ryou Sato, Minami Ito, Hiroko Tsuchiya, Yoshiyuki Ueno   +12 more
doaj   +1 more source

Mobile endoscopy in rural South Africa: outcomes of a decentralised outreach programme to improve gastrointestinal healthcare access. [PDF]

BMJ Open Gastroenterol
Deal M, Karam J, Rychener S, Hailat D, Masood A, Bertram S, Mallah M, Stark H.   +7 more
europepmc   +1 more source

Characterization of pediatric eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis in a nationwide cohort

Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 2, Page 531-540, February 2026.
Abstract Objectives Nonesophageal eosinophilic gastrointestinal disorders (non‐EoE EGIDs) are rare, underrecognized inflammatory diseases of the gastrointestinal (GI) tract, especially in children. Their clinical heterogeneity and lack of specific biomarkers contribute to diagnostic delays and therapeutic challenges.
Sara Renzo, Luca Scarallo, Selene Del Vespa, Giulia Angelino, Matteo Bramuzzo, Enrico Felici, Flavio Labriola, Francesca Laganà, Lorenzo Norsa, Salvatore Oliva, Marisa Piccirillo, Elena Pozzi, Francesca Rea, Giusy Russo, Francesco Valitutti, Giovanna Zuin, Paolo Lionetti   +16 more
wiley   +1 more source

Rare Presentation of Gastric Myeloid Sarcoma. [PDF]

ACG Case Rep J
Jain S, Dickerson A, Moparty B, Kale H.
europepmc   +1 more source

Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions

MedComm, Volume 7, Issue 2, February 2026.
Stem cells offer multifaceted therapeutic approaches for inflammatory diseases, each exhibiting distinct therapeutic properties. Hematopoietic stem cells, primarily through hematopoietic stem cell transplantation (HSCT), can effectively remodel the immune environment, showing particular promise in treating genetically linked cases.
Chen Wu, Zhi‐Ping Jin, Shu‐Qiang Weng, Ji‐Min Zhu, Ling Dong   +4 more
wiley   +1 more source

Quantification of interstitial cells of Cajal and fibrosis during gastric per-oral endoscopic myotomy and its association with clinical outcomes

Endoscopy International Open
Dennis Yang, Muhammad Khalid Hasan, BahaAldeen Bani Fawwaz, Aimen Farooq, Yiyang Zhang, Hafiz M Khan, Tony S Brar, Sanmeet Singh, Artur Viana, Gurdeep Singh, Kambiz Kadkhodayan, Mustafa A Arain, Natalie Cosgrove, Deepanshu Jain, Irteza Inayat, Charanjeet Singh   +15 more
doaj   +1 more source

Filgotinib Is an Effective and Safe Treatment Option for Difficult‐To‐Treat Ulcerative Colitis: Real‐World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Filgotinib is a preferential Janus kinase 1 (JAK‐1) inhibitor registered for the treatment of ulcerative colitis (UC). Real‐world effectiveness of filgotinib, especially for difficult‐to‐treat (DTT, failure of ≥ 2 prior advanced therapies) patients, has been scarcely reported.
M. R. Naber, A.E van der Meulen, P. W. Voorneveld, S. H. C. Veltkamp, A.A. van Bodegraven, A. Bodelier, Z. Mujagic, M. Pierik, L. M. M. Verleye, M. Duijvestein, D. G. Bouwknegt, M. C. Visschedijk, N. Srivastava, R. L. West, B. Oldenburg, M. Löwenberg, F.D.M. van Schaik, On behalf of the Dutch ICC Registry   +17 more
wiley   +1 more source

Upper Gastrointestinal Crohn's Disease: Shedding Light on the Obscure L4 Classification Meaning. [PDF]

J Clin Med
Lusetti F, Bezzio C, De Bernardi A, Puricelli M, Manes G, Saibeni S.   +5 more
europepmc   +1 more source